Published: Apr 30, 2021 | Tags: BMS, US, FDA, Opdivo, sBLA, Priority Review, nivolumab, Muscle Invasive Urothelial Carcinoma
Janssen Reports MAA Submission to EMA for Cilta-cel to Treat Relapsed/ Refractory Multiple Myeloma
Published: Apr 30, 2021 | Tags: Janssen, MAA, Submission, EMA, Cilta-cel, Relapsed/ Refractory, Multiple Myeloma
Published: Apr 30, 2021 | Tags: Repertoire, Yale University, Antigen, T- Cell Receptor, Multiple Sclerosis
Published: Apr 30, 2021 | Tags: Celltrion, Results, Regdanvimab, CT-P59, Pre-Clinical, Study, South African Variant, B.1.351
Published: Apr 30, 2021 | Tags: Innovent, First Patient, Dosing, P-II, Trial, IBI302, Neovascular Age-Related Macular Degeneration
Published: Apr 30, 2021 | Tags: Alphamab, Pfizer, Initiate, P-II, Trial, KN046, Inlyta, axitinib, Non-Small Cell Lung Cancer
Published: Apr 29, 2021 | Tags: Angion, Vifor Pharma, Completion, Patient Enrollment, P-II, AKI-002-15 Study, ANG-3777, Cardiac-Surgery, Acute Kidney Injury
Alcon to Acquire Exclusive US Commercialization Rights to Novartis’ Simbrinza
Published: Apr 29, 2021 | Tags: Alcon, Exclusive, US, Commercialization Rights, Novartis, Simbrinza
Published: Apr 29, 2021 | Tags: BeiGene, Results, Brukinsa (zanubrutinib), P-III, APSEN Trial, R/R Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BioMarin Collaborates with Allen Institute to Develop Gene Therapies for Rare Brain Diseases
Published: Apr 29, 2021 | Tags: BioMarin, Allen Institute, Develop, Gene Therapies, Rare Brain Diseases
Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India
Published: Apr 29, 2021 | Tags: Organicell, Expansion, Trial, Zofin, Treat, COVID-19, India
Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio
Published: Apr 29, 2021 | Tags: Pfizer, Amplyx, Expand, Infectious Disease
Voluntis Collaborates with Eisai to Develop Digital Therapeutics for Oncology Patients
Published: Apr 28, 2021 | Tags: Voluntis, Eisai, Develop, Digital Therapeutics, Oncology
LogicBio Signs an Option Agreement with Canbridge to Develop Gene Editing Therapies
Published: Apr 28, 2021 | Tags: LogicBio, Option Agreement, Canbridge, Develop, Gene Editing Therapies
InveniAI Collaborates with Shionogi on AI-Based Drug Discovery
Published: Apr 28, 2021 | Tags: InveniAI, Shionogi, AI-Based, Drug Discovery
Published: Apr 28, 2021 | Tags: Y-mAbs, MAA, Submission, EMA, Omburtamab, CNS/Leptomeningeal Metastasis, Neuroblastoma
Abbott Launches AI-Powered Coronary Imaging Platform in Europe
Published: Apr 28, 2021 | Tags: Abbott, Launches, AI-Powered, Coronary Imaging Platform, Europe
Published: Apr 28, 2021 | Tags: US, FDA, Priority Review, Takeda, Mobocertinib, TAK-788, EGFR Exon20 Insertion, Metastatic, Non-Small Cell Lung Cancer
Glenmark’s Ryaltris Nasal Spray Receives EC’s Approval as 1L Treatment for Allergic Rhinitis
Published: Apr 27, 2021 | Tags: Glenmark, Ryaltris Nasal Spray, EC, Approval, Treatment, Allergic Rhinitis
Daiichi Sankyo Expands its Collaboration with Esperion to Additional Territories
Published: Apr 27, 2021 | Tags: Daiichi Sankyo, Expands, Esperion, Additional, Territories
Pieris Out-licenses PRS-342 to Boston Pharmaceuticals for ~$363M
Published: Apr 27, 2021 | Tags: Pieris, Out-licenses, PRS-342, Boston Pharmaceuticals, ~$363M
I-Mab Reports Results of Olamkicept (TJ301) in P-II Study for Ulcerative Colitis
Published: Apr 27, 2021 | Tags: I-Mab, Results, Olamkicept, TJ301, P-II Study, Ulcerative Colitis
Medtronic Collaborates with Surgical Theater to Provide Augmented Reality Platform to Neurosurgery
Published: Apr 27, 2021 | Tags: Medtronic, Surgical Theater, Augmented Reality Platform, Neurosurgery
Published: Apr 27, 2021 | Tags: Biocon Biologics, Viatris, European Commission, Approval, Abevmy
Published: Apr 26, 2021 | Tags: AstraZeneca, Tagrisso, osimertinib, EU, CHMP, Positive Opinion, Early-Stage, EGFR-Mutated Lung Cancer
Published: Apr 26, 2021 | Tags: AstraZeneca, MSD, Selumetinib, EU, CHMP, Positive Opinion, First Therapy, Neurofibromatosis Type 1 Plexiform Neurofibromas
Published: Apr 26, 2021 | Tags: Sanofi, AstraZeneca, Results, Nirsevimab, P-III, MELODY Study, Respiratory Syncytial Virus Disease
Published: Apr 26, 2021 | Tags: Dermavant, Results, Tapinarof, Two, P-III, Trials, Psoriasis
Published: Apr 26, 2021 | Tags: GSK, Jemperli, dostarlimab, EC, Approval, Recurrent, Advanced, dMMR/MSI-H, Endometrial Cancer
Published: Apr 26, 2021 | Tags: BMS, Results, Deucravacitinib, Two, P- III Trials, Moderate, Severe, Plaque Psoriasis
Related Post: PharmaShots Weekly Snapshots (Apr 19 – 23, 2021)
The post PharmaShots Weekly Snapshots (Apr 26 – 30, 2021) first appeared on PharmaShots.